By 2027, the global Rx Medical Food Market is expected to reach $30,757.3 million
Rx medical food is a carefully prepared diet or supportive therapy for medical conditions such as pulmonary and metabolic problems. Medical food differs from dietary supplements and prescription medications in that it is nutrient-based, protein-based, and contains minerals and vitamins. Pre-market approval is not required for medical foods. Medical foods were classified as medications by the American Food and Drug Administration (FDA) because they were designed to impact physiological function.
In future years, the global Rx medical food industry is predicted to expand.
Increased demand for medical food in the management of chronic conditions, as
well as public and commercial initiatives in clinical nutrition, are driving
market expansion. Furthermore, market participants' rising expenditure in
medical food research and development is projected to open up new market
prospects. The "Worldwide Rx Medical Food Industry Analysis to 2028"
is a comprehensive and in-depth study that focuses on global market trends. The
report's goal is to give readers a high-level overview of the Rx medical food market,
as well as extensive market segmentation by product type, therapeutic use,
distribution channel, and geography.
During the
projected period, the global Rx medical food market is expected to rise at a
rapid pace. The research includes vital statistics on the main companies'
market positions as well as market trends and opportunities.
The global Rx medical food market is predicted to
be valued at US$ 19,387.3 million in 2020, according to Coherent Market
Insights, with a CAGR of 6.8% over the forecast period (2020-2027).
The global
Rx medical food market is divided into three categories: product type,
therapeutic application, and channel of distribution. The market is divided
into pills, powders, liquids, and others based on product type. The Rx medical
food market is divided into pain management, sleep disorder, neurological
disorder, GI disorder, pulmonary disorders, and metabolic disorders based on
therapeutic application.
The global
Rx Medical Food market is divided into five regions: North America, Latin
America, Europe, Asia Pacific, the Middle East, and Africa. The Rx medical food
market is predicted to be dominated by North America, followed by Europe and The Asia Pacific.
The medical
food category has been explicitly defined and recognized by regulatory agencies
in North America – the US Food and Drug Administration (FDA) – and Europe – the
European Medicine Agency (EMA). In addition, under Food Standards Code 2.9.5,
medical food is controlled in Australia and New Zealand.
Abbott
Laboratories, Danone S.A., Mead Johnson & Company, LLC, Fresenius Kabi AG,
Nestle S.A., Primus Pharmaceuticals, Inc., Targeted Medical Pharma Inc.,
Pivotal Therapeutics Inc., VAYA Pharma, Inc., and AlfaSigma S.P.A. are some of
the major participants in the Rx Medical Food Market.

Comments
Post a Comment